There is no interaction statement
None is printed. The caution panel's general known medical condition clause is doing all of that work, on a formula whose largest ingredient carries a specific cardiac caution in the literature.
The label carries a proper caution panel. Here is what it says, and the one thing it does not.
Memocept's caution panel says not to exceed the recommended dose.
Pregnant or nursing mothers, anyone under 18 and people with a known medical condition should ask a physician before use. L-arginine is not recommended after a recent heart attack, and care is needed alongside nitrates.
Then check how to take it.
This is a dietary supplement, not a drug, and no dietary supplement may lawfully claim to diagnose, treat, cure or prevent a disease. Nothing on this page is medical advice.
The label's own caution panel is printed, complete and correctly worded, and we would follow it exactly: Do not exceed recommended dose. Pregnant or nursing mothers, children under the age of 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement. Keep out of reach of children. Do not use if safety seal is damaged or missing.
Four separate instructions, including the tamper-seal line that a surprising number of labels leave out. On this formula the known medical condition clause is doing more work than it looks like it is.
What follows is the context the label does not carry, sourced and quoted.
The largest amount on this panel is arginine: 200 mg of L-arginine base plus 200 mg of L-arginine AKG 2:1 extract. It is also the ingredient our sources have most to say about, and the important part is not about dose.
The professional monograph we read states: “L-arginine is not recommended following acute myocardial infarction.”
And the reason, in the same source: one trial was terminated early because “8.6% of patients in the L-arginine group died, while no deaths occurred in the control group.”
On interactions: “Caution is warranted in patients concomitantly using L-arginine supplementation and nitrates,” because arginine may potentiate the effects of nitroglycerin and similar medicines. Effects on insulin and cholesterol-lowering drugs are described as unpredictable. Because arginine is a vasodilator, hypotension may occur.
Reported adverse reactions, from the same monograph: nausea, diarrhea, dyspepsia, palpitations, headache, and numbness.
Why this matters on this particular bottle. Memocept is sold for memory. Its audience skews older, and a meaningful share of older adults have had a cardiac event or take nitrates. The label's caution panel reaches them only through its general known medical condition clause, which is correct but requires the buyer to already know that arginine is the relevant word.
And now the fair side of it. Four hundred milligrams is a long way below the 6 to 30 grams a day the monograph's dosage trends describe, and a long way below the amounts used in the trial that was stopped. The honest reading is that the risk at this amount is probably small. The reason we are still giving it a section is that probably is a word a clinician should get to replace — and on this product, uniquely among those this desk has reviewed, they can, because the number is printed.
Ask your doctor before use if you have had a heart attack or take nitrates. Fourteen words, specific to this formula, and the most useful sentence a caution panel on this product could carry.
Beta-alanine. Its characteristic effect is paresthesia — the tingling, prickling or burning that makes pre-workout powders recognisable. The NIH records it at doses of at least 800 mg, or exceeding 10 mg per kilogram of body mass, typically lasting 60 to 90 minutes. This capsule declares 40 mg, which is a twentieth of that threshold. You will feel nothing. That is a genuine comfort and, at the same time, the clearest available measurement of where this amount sits.
Niacin. The reassuring one, and for a good reason rather than a hollow one. The NIH says “thirty to 50 mg or more nicotinic acid typically causes flushing” — the reddening, burning and itching that high-dose niacin produces. This capsule declares 7.5 mg NE. It also sits well under the Tolerable Upper Intake Level of 35 mg for supplemental niacin. No flushing question arises, and the dose is a sensible half-day top-up rather than a pharmacological one.
Citrulline. The NIH is candid about the state of the evidence: “Studies have not adequately assessed the safety of citrulline, particularly when users take it in supplemental form for months at a time.” It notes that in one study 6 of 41 participants reported stomach discomfort, while other short-term trials found no adverse effects. Those studies used grams; this capsule holds 200 mg of the two salts together.
Arginine tolerability, separately from the cardiac question. The NIH records that “up to 9 g/day arginine for several days or weeks is safe and well tolerated”, with gastrointestinal discomfort most commonly reported between 9 and 30 g/day, and that the safety of high-dose arginine beyond three months is not known. Four hundred milligrams sits far below all of that.
Calcium and the excipients. Eighteen milligrams of calcium is 1.4% of a day's worth. Hypromellose, vegetable stearate and silicon dioxide are ordinary capsule materials.
None is printed. The caution panel's general known medical condition clause is doing all of that work, on a formula whose largest ingredient carries a specific cardiac caution in the literature.
One capsule, seven printed amounts. Unlike every other product this desk has reviewed, anyone weighing an interaction here has real numbers to weigh.
The brief says the lot and best-before appear on the base of the bottle when the bottle shows them. Storage is printed: cool, dry, away from heat and light.
Stop taking it and speak to a clinician. For an adverse event, your clinician can report to the FDA's MedWatch programme. For anything about an order, the desk on +1 (507) 448-8190 is the number that can look it up; this website cannot see orders.
We cannot tell you that, and neither can the teal label, because it does not say how much of anything is in it. What we can do is list the specific cautions our sources record and let you take them to a clinician: the huperzine and cholinesterase-inhibitor interaction, the rhodiola and losartan interaction, and the caffeine question.
It matters if you receive the purple bottle. The arginine monograph we read states that “L-arginine is not recommended following acute myocardial infarction”, after a trial was stopped early when 8.6% of the arginine group died against none in the control group. That is a reason to establish which bottle you are being sent before you order.
A class of prescription medicine used in Alzheimer's disease; donepezil, rivastigmine and galantamine are the common ones. The overlap is the point: a supplement sold for memory may be bought by people already taking a prescription for memory. The label's caution panel names no medicine at all, only “a medication” in general.
Then both labels have something for you to raise with a clinician. On the teal one, NCCIH records reported interactions between rhodiola and losartan. On the purple one, the arginine monograph warns about concomitant use with nitrates and describes effects on other drugs as unpredictable.
Not published. Caffeine from green coffee bean is the first ingredient in the blend, which by the descending-order rule means it is the heaviest of the seven and could in principle be the entire 151 mg. No milligram figure appears on the label, in the brief or on the listing.
Ask the person who prescribes it, and take both panels with you. The two specific interactions in our sources are huperzine A with cholinesterase inhibitors and rhodiola with losartan, and on the other label arginine carries a caution about nitrates. Both labels' caution panels say to consult a physician if you are taking a medication.
For huperzine A the monograph lists hyperactivity, nasal obstruction, nausea, vomiting, diarrhea, insomnia, anxiety, dizziness, thirst and constipation. For bacopa, flu-like symptoms, GI irritation, nausea, increased intestinal motility and muscle fatigue. For rhodiola, dizziness, headache, insomnia and dry mouth or excess saliva. None of those is on this product's label.
40 mg, against a studied range of 1.6 to 6.4 grams a day over four to eight weeks. The same NIH source notes that beta-alanine causes tingling or burning at doses of at least 800 mg, so at 40 mg you will feel nothing — which is both a comfort and a measurement.
They are the best-made part of the teal label. Vitamin B1 at 6 mg, B6 at 8.5 mg and B12 at 24 mcg, and all three printed percentages are arithmetically correct against the FDA's Daily Values of 1.2 mg, 1.7 mg and 2.4 mcg. Whether you need them depends on your diet, and a supplement is not the only way to get them.
Both labels say no, in their own caution panels, and the brief says adults 18 and over. NCCIH also notes that little is known about whether rhodiola is safe during pregnancy or breastfeeding.
No. Both labels say so explicitly.
Take the next one at the usual time. Do not double up — both labels say not to exceed the recommended dose, and on a formula with an undeclared caffeine content that instruction has teeth.
Not on the artwork supplied to us. The brief says the lot and best-before appear on the base of the bottle when the bottle shows them. The lot reference given is MEM-26/ME-2440.
One bottle is 30 capsules at one a day, so a bottle is thirty days and the 60-day guarantee still has thirty left to run when it ends. The guarantee runs from purchase, not from delivery, and the price is shown at checkout.
Order NowRead the label firstNo price was published to us. We print no figure we have not seen ourselves. · 60-day guarantee from purchase · Not for under 18, pregnancy or nursing